Skip to main content
main-content

Type 2 diabetes

Healthcare systems

11-28-2018 | Linagliptin | News

Linagliptin preferable to insulin in majority of surgical type 2 diabetes patients

Daily linagliptin is effective and reduces hypoglycemia risk relative to multidose insulin in type 2 diabetes patients with mild-to-moderate hyperglycemia who are undergoing non-cardiac surgery, suggest the results of a randomized controlled study.

Source:

Diabetes Obes Metab 2018; doi:10.1111/dom.13587

11-20-2018 | Healthcare costs | News

High-deductible insurance linked to delays in care for diabetes complications

Compulsory enrollment in a high-deductible health insurance plan is associated with significant delays in seeking care for macrovascular complications among people with diabetes, US research shows.

Source:

Ann Intern Med 2018; doi:10.7326/M17-3365

11-03-2018 | Premixed insulins | Review | Article

Expert opinion: Patient selection for premixed insulin formulations in diabetes care

Kalra S et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0521-2

08-22-2018 | Psychosocial care | Editorial | Article

Shared decision-making in patient-centered care

Is the medical model of care failing diabetes patients in its current form? Advisory Board member Katharine Barnard considers this, and the future of clinical decision support.

Author:
Katharine Barnard

08-17-2018 | Insulin pumps | Review | Article

An overview of safety issues on use of insulin pumps and continuous glucose monitoring systems in the hospital

Thompson B et al. Curr Diab Rep 2018; 18: 81. doi: 10.1007/s11892-018-1056-7

08-15-2018 | Pregnancy | Review | Article

Inpatient glycemic management of the pregnant patient

Yeh T, Yeung M, Mendelsohn Curanaj FA. Curr Diab Rep 2018; 18: 73. doi: 10.1007/s11892-018-1045-x

07-23-2018 | SGLT2 inhibitors | Review | Article

SGLT2 inhibitors in type 2 diabetes management: Key evidence and implications for clinical practice

Wilding J et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0471-8

07-17-2018 | Primary care | News

HbA1c valid marker of blood glucose in anemia or CKD

The presence of mild-to-moderate anemia or chronic kidney disease does not have a clinically significant effect on the interpretation of glycated hemoglobin as a marker of glycemic control, Danish research shows.

Source:

Diabet Med 2018; doi: 10.1111/dme.13776

07-16-2018 | Quality of life | Editorial | Article

Tackling clinical inertia: The role of patient engagement

Carmen Soto and David Strain provide their insights on clinical inertia in diabetes care and present the co-production model of open communication as an innovative means to address this widespread clinical issue.

Authors:
Carmen Soto, David Strain MD FCRP

07-14-2018 | Pediatrics | Review | Article

Disparities in care delivery and outcomes in young adults with diabetes

Agarwal S, Hilliard M, Butler A. Curr Diab Rep 2018; 18: 65. doi: 10.1007/s11892-018-1037-x

07-04-2018 | Mental health | Article

Factors associated with type 2 diabetes in patients with vascular dementia: A population-based cross-sectional study

Liu CL et al. BMC Endocr Disord 2018; 18: 45. doi: 10.1186/s12902-018-0273-z

06-26-2018 | Diabetic foot | Article

Community based study to assess the prevalence of diabetic foot syndrome and associated risk factors among people with diabetes mellitus

Vibha SP et al. BMC Endocr Disord 2018; 18: 43. doi: 10.1186/s12902-018-0270-2

06-26-2018 | Artificial pancreas systems | Highlight | News

Closed-loop delivery improves inpatient glucose control in type 2 diabetes

Fully closed-loop insulin delivery results in a markedly improved time in range among inpatients with type 2 diabetes receiving noncritical care, researchers have reported.

Source:

N Engl J Med 2018; Advance online publication

06-23-2018 | Type 2 diabetes | ADA 2018 | News

Primary care-based QI initiative improves glucose control in type 2 diabetes

A primary care-based diabetes quality improvement initiative using a shared medical appointment approach leads to increased insulin use and reduced glycated hemoglobin in patients with poorly controlled type 2 diabetes, research shows.

06-16-2018 | Cardiovascular disorders | Review | Article

Inpatient glycemic management of non-cardiac CVD: Focus on stroke and PVD

Everett E, Mathioudakis N. Curr Diab Rep 2018; 18: 49. doi: 10.1007/s11892-018-1026-0

06-16-2018 | Medications | Review | Article

Availability and affordability of essential medicines: Implications for global diabetes treatment

Beran D et al. Curr Diab Rep 2018; 18: 48. doi: 10.1007/s11892-018-1019-z

image credits